Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094317 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alejandro Mejía-García und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada. Hauptthemen laut MEDLINE: Uveal Neoplasms, Melanoma, Extracellular Matrix, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Uveal melanoma (UVM) is an aggressive cancer with a poor prognosis, particularly in metastatic cases. This study aimed to develop and validate a novel extracellular matrix (ECM) gene expression signature to predict prognosis and stratify patients by risk. ECM-related genes were identified and used to construct a prognostic model through Lasso–Cox regression analysis, leveraging RNA sequencing data from 80 UVM patients in The Cancer Genome Atlas (TCGA). The model was validated using an independent cohort of 63 UVM patients. Survival analyses, immune infiltration profiling, and functional enrichment analyses were conducted to evaluate the biological significance and clinical utility of the signature. The ECM signature stratified patients into high- and low-risk groups with significant differences in survival outcomes. High-risk patients showed elevated expression of MMP1 and MMP12, which are associated with ECM remodeling and immune modulation, alongside increased infiltration of immunosuppressive cells, such as M2 macrophages. Validation confirmed the prognostic value of the signature across cohorts. Functional analyses highlighted the involvement of ECM-related pathways, epithelial–mesenchymal transition, and immune system interactions in tumor progression. This ECM gene expression signature is a robust prognostic tool for UVM, offering insights into tumor biology and immune microenvironment interactions. It holds promise for improving patient stratification and guiding personalized therapeutic strategies. Further research is warranted to explore the functional roles of these genes in UVM progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada.
- Cancer Biology Research Group, Instituto Nacional de Cancerología, Bogotá 110311, Colombia.
- Translational Research Group in Oncology, Instituto Nacional de Cancerología, Bogotá 110311, Colombia.
- Department of Biomedical and Health Sciences, University of Vermont, 106 Carrigan Drive, 302 Rowell, Burlington, VT 04505, USA.
- Master Program in Epidemiology, Fundación Universitaria del Área Andina, Bogotá 110311, Colombia.
- Health and Sport Sciences Research Group, School of Health and Sport Sciences, Fundación Universitaria del Área Andina, Bogotá 110311, Colombia.
ORCID-Profile: Julius Herzog, Marcela Ramírez, Johanna González, Yina Zambrano, Alba Lucia Combita, Diego A Bonilla, Seth Frietze
Zitieren
APA
Mejía-García, A., Orozco, C. A., Herzog, J., Alarcón-Betancourth, O., Meneses-Torres, A., Ramírez, M., González, J., Zambrano, Y., Combita, A. L., Bonilla, D. A., & Frietze, S. (2025). Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094317
Vancouver
Mejía-García A, Orozco CA, Herzog J, Alarcón-Betancourth O, Meneses-Torres A, Ramírez M, et al. Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094317
BibTeX
@article{MejaGarca2025,
author = {Mejía-García, Alejandro and Orozco, Carlos A and Herzog, Julius and Alarcón-Betancourth, Oscar and Meneses-Torres, Alexandra and Ramírez, Marcela and González, Johanna and Zambrano, Yina and Combita, Alba Lucia and Bonilla, Diego A and Frietze, Seth},
title = {Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094317}
}
EUVIMED